| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 5 |
| GO:0110165 | cellular anatomical entity | 1 | 5 |
Related structures:
AlphaFold database: A4I5X2
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 128 | 132 | PF00656 | 0.438 |
| CLV_NRD_NRD_1 | 166 | 168 | PF00675 | 0.661 |
| CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.654 |
| CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.667 |
| CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.635 |
| DEG_APCC_DBOX_1 | 9 | 17 | PF00400 | 0.415 |
| DOC_CYCLIN_yCln2_LP_2 | 77 | 83 | PF00134 | 0.383 |
| DOC_MAPK_gen_1 | 166 | 177 | PF00069 | 0.483 |
| DOC_PP4_FxxP_1 | 177 | 180 | PF00568 | 0.408 |
| DOC_PP4_FxxP_1 | 187 | 190 | PF00568 | 0.428 |
| DOC_WW_Pin1_4 | 176 | 181 | PF00397 | 0.450 |
| DOC_WW_Pin1_4 | 95 | 100 | PF00397 | 0.462 |
| LIG_14-3-3_CanoR_1 | 10 | 14 | PF00244 | 0.449 |
| LIG_14-3-3_CanoR_1 | 166 | 174 | PF00244 | 0.419 |
| LIG_FHA_1 | 69 | 75 | PF00498 | 0.462 |
| LIG_FHA_1 | 76 | 82 | PF00498 | 0.376 |
| LIG_LIR_Apic_2 | 184 | 190 | PF02991 | 0.466 |
| LIG_LIR_Nem_3 | 159 | 165 | PF02991 | 0.341 |
| LIG_LIR_Nem_3 | 26 | 32 | PF02991 | 0.609 |
| LIG_MYND_1 | 137 | 141 | PF01753 | 0.423 |
| LIG_Pex14_2 | 187 | 191 | PF04695 | 0.497 |
| LIG_SH2_STAT3 | 32 | 35 | PF00017 | 0.420 |
| LIG_SH2_STAT5 | 27 | 30 | PF00017 | 0.620 |
| LIG_SH2_STAT5 | 32 | 35 | PF00017 | 0.489 |
| LIG_WRC_WIRS_1 | 69 | 74 | PF05994 | 0.451 |
| MOD_CDK_SPxK_1 | 95 | 101 | PF00069 | 0.462 |
| MOD_CK1_1 | 4 | 10 | PF00069 | 0.562 |
| MOD_CK2_1 | 148 | 154 | PF00069 | 0.444 |
| MOD_GlcNHglycan | 150 | 153 | PF01048 | 0.668 |
| MOD_GlcNHglycan | 18 | 21 | PF01048 | 0.427 |
| MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.489 |
| MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.678 |
| MOD_GSK3_1 | 64 | 71 | PF00069 | 0.488 |
| MOD_NEK2_1 | 129 | 134 | PF00069 | 0.470 |
| MOD_NEK2_1 | 23 | 28 | PF00069 | 0.318 |
| MOD_PIKK_1 | 64 | 70 | PF00454 | 0.455 |
| MOD_PKA_1 | 166 | 172 | PF00069 | 0.458 |
| MOD_PKA_2 | 165 | 171 | PF00069 | 0.452 |
| MOD_PKA_2 | 9 | 15 | PF00069 | 0.364 |
| MOD_Plk_1 | 183 | 189 | PF00069 | 0.407 |
| MOD_Plk_1 | 56 | 62 | PF00069 | 0.463 |
| MOD_Plk_4 | 23 | 29 | PF00069 | 0.355 |
| MOD_Plk_4 | 4 | 10 | PF00069 | 0.550 |
| MOD_ProDKin_1 | 176 | 182 | PF00069 | 0.449 |
| MOD_ProDKin_1 | 95 | 101 | PF00069 | 0.462 |
| TRG_ER_diArg_1 | 165 | 167 | PF00400 | 0.454 |
| TRG_NES_CRM1_1 | 64 | 75 | PF08389 | 0.381 |
| TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.657 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PCB6 | Leptomonas seymouri | 61% | 100% |
| A0A0S4ITI4 | Bodo saltans | 32% | 83% |
| A0A1X0P1H2 | Trypanosomatidae | 36% | 97% |
| A0A3Q8IJN4 | Leishmania donovani | 99% | 100% |
| A0A3R7M429 | Trypanosoma rangeli | 39% | 100% |
| A4HIM7 | Leishmania braziliensis | 83% | 100% |
| C9ZR96 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 40% | 100% |
| E9B166 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
| Q4Q6Z9 | Leishmania major | 95% | 100% |